Friday's Medical PRs. VITAMIN SHOPPE 72 HOUR D
Post# of 63824
Posted On: 07/06/2013 12:58:10 PM
Friday's Medical PRs.
- VITAMIN SHOPPE 72 HOUR DEADLINE ALERT: Approximately 72 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Securities Class Action Lawsuit Against Vitamin Shoppe, Inc.
10:00 pm - Business Wire - Calyx Announces Second and Final Closing of Non-Brokered Private Placement
6:45 pm - Marketwire - Dr. Douglas M. Weissman, MD, FACP is recognized by Continental Who's Who as a Pinnacle Professional in the field of Medicine
6:02 pm - PR Newswire - Summer is the Perfect Time for a Smile that Shines from Hamlin Dental Group
5:00 pm - PR Newswire - XenoPort Announces New Employment Inducement Awards
5:00 pm - Business Wire - Find Out about Laser Vein or Hair Removal before Bikini Season is Over
4:46 pm - PR Newswire - Back Pain Can Spread after Improper Treatment, says S.M. Rezaian, MD, FRCS, FICS, PhD
4:44 pm - PR Newswire - Paladin Labs Inc. and Bioniche Life Sciences Inc. Officially Close Debt Refinancing and Urocidin(TM) Licensing Deals
4:12 pm - Marketwire - PerkinElmer to Hold Earnings Call on Thursday, August 1, 2013
4:05 pm - Business Wire - Avanir Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
4:00 pm - PR Newswire - Paladin Labs Inc. and Bioniche Life Sciences Inc. Officially Close Debt Refinancing and Urocidin(TM) Licensing Deals
3:35 pm - Marketwire - Laboratoires Paladin Inc. et Bioniche Life Sciences Inc. concluent officiellement le refinancement de la dette et signent une entente de licence pour Urocidin(MC)
3:35 pm - Marketwire - Biosign Investor Conference Call scheduled
3:08 pm - CNW Group - Paladin Labs Inc. and Bioniche Life Sciences Inc. Officially Close Debt Refinancing and Urocidin™ Licensing Deals
3:06 pm - PR Newswire - Aspen Dental And Stewart-Haas Racing Celebrate Smiles During NASCAR Sprint Cup Coke Zero 400 Powered By Coke At Daytona International Speedway
3:05 pm - PR Newswire - Researchers at Children’s Hospital Los Angeles Discover a Potential Structural Basis for ADHD in Brain of Preterm Newborns
2:16 pm - Business Wire - Research and Markets: Global Spine Surgery Devices Market is Poised to Grow at a CAGR of 5.1% to Reach $14,833 Million by 2017
1:24 pm - Business Wire - Research and Markets: Global Vena Cava Filters Market 2012-2016 with C.R. Bard Inc., Cook Medical Inc., and Cordis Corp. Dominating
1:18 pm - Business Wire - Research and Markets: Allergan Limited - Product Pipeline Review - 2013 Available Now for Analysis
12:39 pm - Business Wire - Regence Offers Oregon Employers Big Benefits Through New Professional Employer Organization Agreement
12:05 pm - PR Newswire - Research and Markets: Tapping Social Media for Clinical Trial Recruitment - 2013: 80% of Clinical Trials Are Currently Failing To Achieve Enrollment Goals
11:58 am - Business Wire - CorMedix Receives CE Mark for Neutrolin® Catheter Lock Solution
11:05 am - Business Wire - CLINATEC Chairman Alim-Louis Benabid Honored by Michael J. Fox Foundation for Pioneering Work in Treating Parkinson’s Disease
10:56 am - Business Wire - Rafarma Pharmaceuticals, Inc. (RAFA) Enters Into New Production Contract for Para-Aminosalicylic Acid
10:27 am - Marketwire - Beverly Hills Cosmetic Dentist, Parsa Zadeh DDS, Offers Various Teeth Whitening Treatments
10:00 am - GlobeNewswire - Medical Tourism Association(R)-University of Miami Partnership Offering First Continuing Education Credits in Medical Tourism
9:47 am - Marketwire - Research and Markets: PharmaPoint: Dermatophytic Onychomycosis (DO) - Current and Future Players
9:19 am - Business Wire - Leonhardt Ventures to Present Cardiovascular and Heart Disease Technology Showcase @ University of Minnesota
9:15 am - PR Newswire - Research and Markets: CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Spain
9:13 am - Business Wire - Research and Markets: PharmaPoint: Dermatophytic Onychomycosis (DO) - US Drug Forecast and Market Analysis to 2022
9:12 am - Business Wire - Northridge Dentist, Dr. Ariz, is Now Offering Treatments for Sleep Apnea
9:00 am - PR Newswire - Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program
8:30 am - GlobeNewswire - Elsevier Promotes Local Research Efforts in Pakistan Through "Quiz for Science"
8:01 am - PR Newswire - U.S. FDA Approves Zubsolv® for the Maintenance Treatment of Opioid Dependence
8:00 am - PR Newswire - Research and Markets: Germany Health and Wellness Industry Outlook to 2017 - Health Clubs and Spas to Witness Strong Growth
7:43 am - Business Wire - Registration is Open for the Dotmatics UGM 2013
7:42 am - Business Wire - Theragenics Signs Brachytherapy Supply and Reseller Agreement with UK-Based Accelyon
7:30 am - Business Wire - Mary K. Pendergast Appointed to Impax Laboratories Board of Directors
7:30 am - Business Wire - Top Vivus shareholder says proxy firm ISS backs three of nine board nominees
7:16 am - Reuters - Two Leading Proxy Advisory Firms Reject FMC's Attempt to Take Control of VIVUS's Board
7:00 am - GlobeNewswire - Cyclacel Pharmaceuticals to Present at the JMP Securities Healthcare Conference 2013
7:00 am - GlobeNewswire - Research and Markets: Incontinence Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2019
6:47 am - Business Wire - Research and Markets: Cardiovascular Disease - Pipeline Review, H1 2013
6:21 am - Business Wire - ISS and Egan Jones Recommend That Vivus Stockholders Vote for First Manhattan’s Nominees for Election to Vivus Board
6:00 am - Business Wire - Research and Markets: Dry (Atrophic) Macular Degeneration - Pipeline Review, H1 2013
5:24 am - Business Wire - Research and Markets: Pseudomonas Infections - Pipeline Review, H1 2013
5:05 am - Business Wire - Baxter Presents ADVATE Data on Prophylaxis Management and Efficacy for Hemophilia A Patients
3:00 am - Business Wire - China starts probe into Tetra Pak 'dominance': media
2:57 am - Reuters
(0)
(0)